A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer
暂无分享,去创建一个
R. Doebele | Jihye Kim | A. Tan | L. Heasley | R. Nemenoff | C. McCoach | T. Patil | D. Merrick | T. Hinz | N. Gurule | Jacob Calhoun | A. Van Bokhoven | A. Tan